Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-26-033169

Options or other derivatives

  • DIRECTOR AND CMO - TRANS. MED. acquired 1,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MAIDA ANTHONY E III DIRECTOR AND CMO - TRANS. MED. 2026-07-10 Grant or award · Restricted stock Units +1,500 1,500 D
Loading xslF345X06/ownership.xml…